Gary P. Smaby, Board Chair
John A. Rollwagen, Director

Gary P. Smaby, Board Chair
Gary Smaby is a principal at Quatris Fund, a venture capital fund that offers promising Minnesota-based companies start-up financing and strategic advice. Following a successful ten-year entrepreneurial career, Mr. Smaby joined the Minneapolis-based investment banking firm of Piper Jaffray in 1982 where he built an international reputation as a leading Wall Street analyst in the information technology sector, encompassing a broad spectrum from high-performance workstations and supercomputers to networking and decision support systems. After forming Smaby Group, Inc. in 1989, Mr. Smaby set out to use his experience and contacts to keep clients abreast of the emerging trends that shape the technology landscape. Over the last decade, his retainer clients have included corporate giants like AT&T, Cray, HP, IBM, Intel, SGI, Sun, and Unisys, as well as many high-profile start-ups. He also serves on the boards of many companies and institutions, including Algos Therapeutics. Mr. Smaby is a 1971 Cum Laude graduate from St. Olaf College. To learn more about Quatris Fund, visit http://www.quatrisfund.com.

John A. Rollwagen, Director
For the last decade, John Rollwagen has been an investor and business advisor specializing in information technology. He is currently a principal at Quatris Fund, a venture capital fund that offers promising Minnesota-based companies start-up financing and strategic advice. Mr. Rollwagen has been affiliated with St. Paul Venture Capital as an advisor and venture partner since 1993. Prior to that, he was chairman and chief executive officer of Cray Research, Inc., the leading supplier of supercomputers worldwide. During his tenure, he led Cray Research from a start-up operation with less than 100 people to a highly profitable and internationally respected Fortune 500 company with annual revenues in excess of $800 million and more than 5,000 employees in 21 countries. Mr. Rollwagen serves on several public and private company boards including the board of directors for Algos Therapeutics. Mr. Rollwagen earned his MBA from the Harvard Business School and his BSEE from the Massachusetts Institute of Technology. To learn more about Quatris Fund, visit http://www.quatrisfund.com.